Food and Microbiome Longitudinal Investigation (FAMiLI)
NYU Langone Health · with National Cancer Institute (NCI) · NCT03293758
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 40+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 16000
- US sites recruiting
- 1
- Study start
- May 16, 2016
- Record last updated
- February 25, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The NYU Human Microbiome Study Cohort is designed to improve understanding of the role of human microbiome in health and disease. This study will serve as a critical NYU biorepository resource for research on human genetics and the microbiome in health and disease
Conditions: Cancer; Cardiovascular Diseases
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Age > 40
Exclusion Criteria
- Use of long term antibiotics.
- Pregnant
Recruiting US locations
New York University School of Medicine
New York, NY 10016
Site contact: Dia Beggs · 646-501-3396 · dia.beggs@nyulangone.org
Study contacts (from the official record)
- Zelle Halloran · 646-501-3673 · Zelle.Halloran@nyulangone.org
- Jiyoung Ahn, PhD · 646-501-3373 · jiyoung.ahn@nyulangone.org
Similar studies in New York
All heart & blood pressure studies in New York →- RecruitingHealthy volunteers
BoxX-NoAF Clinical Trial
AtriCure, Inc.
- Location
- Manhasset, NY + 30 other US sites
- Eligibility basics
- Ages 65+
- RecruitingHealthy volunteers
AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
Peerbridge Health, Inc
- Location
- New York, NY + 7 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Assessment of CCM in HF With Higher Ejection Fraction
Impulse Dynamics
- Location
- Buffalo, NY + 64 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1
Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia
Verve Therapeutics, Inc.
- Location
- New York, NY + 4 other US sites
- Eligibility basics
- Ages 18–70